Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $4.2050 (-5.61%) ($4.2050 - $4.5200) on Mon. Aug. 22, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.68% (three month average) | RSI | 71 | Latest Price | $4.2050(-5.61%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -4.6% a day on average for past five trading days. | Weekly Trend | ATRA advances 13.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XLK(97%) PAVE(94%) SPY(93%) GDX(89%) XLC(87%) | Factors Impacting ATRA price | ATRA will decline at least -5.34% in a week (0% probabilities). UUP(-43%) TIP(-22%) USO(6%) SHY(7%) BNDX(14%) | | | | | Relative Volatility | | | | Market Trend Strength | -5.34% (StdDev 10.68%) | Hourly BBV | -2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $4.62(-8.98%) | 10 Day Moving Average | $4.84(-13.12%) | 20 Day Moving Average | $4.08(3.06%) | To recent high | -52.1% | To recent low | 47.3% | Market Cap | $312m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |